Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point-of-care GlycoStrips detect serum and salivary antibodies to blood group antigens and pathogens.

Trends in biotechnology·2026
Same author

Introduction to a Special Issue of Glycobiology-Glycobiology Reviews Cancer.

Glycobiology·2026
Same author

N-glycopedia: libraries for native N-glycan structural analysis.

Nature communications·2026
Same author

An atlas of human siglecs integrates expression, affinity, and cis/trans sialoglycan recognition profiles.

Nature communications·2026
Same author

Disrupted O-GalNAc glycosylation as a mechanism and biomarker of <i>SLC35A2</i>-associated epilepsy.

bioRxiv : the preprint server for biology·2026
Same author

Deletion of Core 1 β3GalT-specific molecular chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis.

The Journal of biological chemistry·2026

Related Experiment Video

Updated: Jul 4, 2025

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

15.7K

Serum antibody screening using glycan arrays.

Samantha Marglous1, Claire E Brown1, Vered Padler-Karavani2

  • 1Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA. gildersj@mail.nih.gov.

Chemical Society Reviews
|February 2, 2024
PubMed
Summary

Anti-glycan antibodies are crucial for immunity and disease, offering insights into health. Glycan microarrays rapidly analyze these antibodies, identifying biomarkers and vaccine responses.

More Related Videos

Printed Glycan Array: A Sensitive Technique for the Analysis of the Repertoire of Circulating Anti-carbohydrate Antibodies in Small Animals
08:49

Printed Glycan Array: A Sensitive Technique for the Analysis of the Repertoire of Circulating Anti-carbohydrate Antibodies in Small Animals

Published on: February 14, 2019

6.9K
Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

9.5K

Related Experiment Videos

Last Updated: Jul 4, 2025

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

15.7K
Printed Glycan Array: A Sensitive Technique for the Analysis of the Repertoire of Circulating Anti-carbohydrate Antibodies in Small Animals
08:49

Printed Glycan Array: A Sensitive Technique for the Analysis of the Repertoire of Circulating Anti-carbohydrate Antibodies in Small Animals

Published on: February 14, 2019

6.9K
Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

9.5K

Area of Science:

  • Immunology
  • Glycobiology
  • Biomarker Discovery

Background:

  • Antibodies targeting carbohydrate structures (glycans) are vital for immune defense against pathogens and cancer.
  • Dysregulated anti-glycan antibodies can cause autoimmune diseases.
  • Serum anti-glycan antibody profiles reflect health status, vaccination history, and disease presence.

Purpose of the Study:

  • To review the applications of glycan microarray technology for profiling serum anti-glycan antibodies.
  • To highlight the utility of glycan microarrays in identifying novel biomarkers and analyzing immune responses.

Main Methods:

  • Glycan microarrays enable high-throughput interrogation of serum anti-glycan antibodies.
  • This technology allows for detailed analysis of antibody binding specificities.
  • Review of existing literature on glycan microarray applications in immunology and diagnostics.

Main Results:

  • Glycan microarrays facilitate rapid identification of disease-specific and vaccine-induced anti-glycan antibody signatures.
  • The technology aids in understanding immune responses to various stimuli.
  • Applications span infectious diseases, cancer, and autoimmune disorders.

Conclusions:

  • Glycan microarray technology is a powerful tool for serum anti-glycan antibody profiling.
  • It offers significant potential for biomarker discovery and personalized medicine.
  • Further applications in diagnostics and therapeutic monitoring are anticipated.